SAN DIEGO, Nov. 14, 2019 /PRNewswire/ -- Evofem
Biosciences, Inc. (NASDAQ: EVFM) today announced that Chief
Executive Officer Saundra Pelletier
was named a 2019 Business Woman of the Year by the San Diego
Business Journal. The publication's annual awards program,
hosted Wednesday, November 13,
recognized 15 dynamic women business leaders who have contributed
significantly to San Diego's
workplaces and communities.
"I am honored to be recognized among such an accomplished group
of women who are making a difference in San Diego and beyond," said Ms. Pelletier. "As
a mother, daughter and CEO of a female-forward company developing
an innovative new hormone-free, on-demand contraceptive, I am
inspired by this tribe of influential female leaders, who are also
passionate and selfless role models. Together, we are broadening
the definition of leadership and empowering future generations of
women to pave their own unique paths forward."
Ms. Pelletier has served as Chief Executive Officer of Evofem
Biosciences, Inc. since 2015. During her tenure, she has led the
Company through a successful transition to the public market and
multiple rounds of equity financing, which have raised in excess of
$245 million. She has dedicated her
career to advancing women's health and expanding their sexual and
reproductive health choices with options that they control.
Winners were selected by an independent judging panel based on
their innovation, entrepreneurship, professional accomplishment and
community leadership. Of the more than 200 nominations received, 96
were named finalists and 15 women were selected as award
winners.
About Evofem Biosciences, Inc.
Evofem Biosciences,
Inc. is a clinical-stage biopharmaceutical company committed to
developing and commercializing innovative products to address unmet
needs in women's sexual and reproductive health. Evofem Biosciences
aims to advance the lives of women by developing novel solutions,
such as woman-controlled contraception and potential protection
from certain sexually transmitted infections. The Company is
leveraging its proprietary Multipurpose Vaginal pH Regulator
(MVP-R™) platform to develop Amphora® (L-lactic
acid, citric acid and potassium bitartrate) for hormone-free birth
control and prevention of chlamydia. For more information, please
visit www.evofem.com.
Amphora® is a registered trademark and
Multipurpose Vaginal pH Regulator (MVP-R™) is a trademark of Evofem
Biosciences, Inc.
Media Contact
Cara
Miller
Evofem Biosciences, Inc.
cmiller@evofem.com
O: (858) 550-1900 x272
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-ceo-saundra-pelletier-awarded-2019-business-woman-of-the-year-300958059.html
SOURCE Evofem Biosciences, Inc.